Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review BI Gaynes, R Fiscella Drug safety 25, 233-250, 2002 | 230 | 2002 |
Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension BI Gaynes, A Onyekwuluje Clinical ophthalmology 2 (2), 355-368, 2008 | 111 | 2008 |
Quantitative assessment of conjunctival microvascular circulation of the human eye M Shahidi, J Wanek, B Gaynes, T Wu Microvascular research 79 (2), 109-113, 2010 | 78 | 2010 |
Factors predicting visual acuity outcome in intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment (MUST) trial JH Kempen, ML Van Natta, MM Altaweel, JP Dunn, DA Jabs, SL Lightman, ... American journal of ophthalmology 160 (6), 1133-1141. e9, 2015 | 44 | 2015 |
Refractive astigmatism after oblique clear corneal phacoemulsification cataract incision BJ Jacobs, BI Gaynes, TA Deutsch Journal of Cataract & Refractive Surgery 25 (7), 949-952, 1999 | 41 | 1999 |
Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease J Wanek, B Gaynes, JI Lim, R Molokie, M Shahidi American journal of hematology 88 (8), 661-664, 2013 | 34 | 2013 |
Conjunctival microvascular haemodynamics in sickle cell retinopathy A Kord Valeshabad, J Wanek, R Zelkha, JI Lim, N Camardo, B Gaynes, ... Acta ophthalmologica 93 (4), e275-e280, 2015 | 33 | 2015 |
Assessment of microvascular circulation M Shahidi, J Wanek, B Gaynes US Patent 8,801,183, 2014 | 30 | 2014 |
Comparison of glucose, sorbitol and fructose accumulation in lens and liver of diabetic and insulin-treated rats and mice. BI Gaynes, JB Watkins 3rd Comparative Biochemistry and physiology. B, Comparative Biochemistry 92 (4 …, 1989 | 28 | 1989 |
Retinal toxicity of chloroquine hydrochloride administered by intraperitoneal injection BI Gaynes, E Torczynski, Z Varro, R Grostern, J Perlman Journal of Applied Toxicology 28 (7), 895-890, 2008 | 27 | 2008 |
Equivalence of generic and brand-name ophthalmic products RG Fiscella, BI Gaynes, M Jensen American Journal of Health-System Pharmacy 58 (7), 616-617, 2001 | 24 | 2001 |
Innovations in topical ocular corticosteroid therapy for the management of postoperative ocular inflammation and pain CL Salinger, BI Gaynes, RK Rajpal Am J Manag Care 25 (12 Suppl), S215-S226, 2019 | 21 | 2019 |
Impact of administration angle on the cost of artificial tear solutions: does bottle positioning minimize wastage? BI Gaynes, RM Singa, G Schaab, Y Sorokin Journal of ocular pharmacology and therapeutics 23 (2), 196-201, 2007 | 21 | 2007 |
Dissociations of the fluocinolone acetonide implant: the Multicenter Uveitis Steroid Treatment (MUST) trial and follow-up study JT Holbrook, EA Sugar, AE Burke, AT Vitale, JE Thorne, JL Davis, ... American journal of ophthalmology 164, 29-36, 2016 | 19 | 2016 |
Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration BI Gaynes, RG Fiscella Expert Opinion on Drug Safety 3 (4), 345-361, 2004 | 19 | 2004 |
Analgesics in ophthalmic practice: a review of the oral non-narcotic agent tramadol BI Gaynes, RL Barkin Optometry and vision science 76 (7), 455-461, 1999 | 19 | 1999 |
Feasibility of conjunctival hemodynamic measurements in rabbits: reproducibility, validity, and response to acute hypotension B Gaynes, PYU TENG, J Wanek, M Shahidi Microcirculation 19 (6), 521-529, 2012 | 18 | 2012 |
Neuroticism modifies the association of vision impairment and cognition among community-dwelling older adults BI Gaynes, R Shah, S Leurgans, D Bennett Neuroepidemiology 40 (2), 142-146, 2013 | 16 | 2013 |
Therapeutic solution drop dispenser BI Gaynes US Patent 7,527,613, 2009 | 16 | 2009 |
AREDS misses on safety BI Gaynes Archives of ophthalmology 121 (3), 416-417, 2003 | 16 | 2003 |